Clinical Trial Update: A Novel CAR-T Combined Expression of IL-15 in the Treatment of Malignant Hematological Tumors [NA]

View source ↗

Summary

A Clinical Trial Update describes a novel CAR-T therapy expressing IL-15 for malignant hematological tumors, with recruitment ongoing and no phase information a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Multiple Myeloma
• Non-hodgkin Lymphoma

Snippet

Sponsor: Shanxi Bethune Hospital | Conditions: Acute Lymphocytic Leukemia, Lymphoma,Non-Hodgkin | NA | Status: RECRUITING